Dentin Sensitivity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Healthy volunteers; male or female aged between 20 and 65 years; with healthy periodontium; no periodontitis or gingivitis; presenting teeth without the presence of caries, cracks, fractures or extensive restorations; presenting teeth without premature contact; volunteers who have understood the study design; volunteers who have at least four sensitive teeth in their mouths, one in each oral quadrant; volunteers who have signed and agreed to the Informed Consent Form
Exclusion criteria
Exclusion criteria: Pregnant or breastfeeding women; subjects registered in another clinical trial; individuals who underwent professional treatment for hypersensitivity, or who used desensitizing products in the 3 months preceding the research period; history of maxillofacial cancer in the last 5 years; need for systemic treatment due to infection; patients who make chronic use of anti-inflammatory drugs, analgesics or psychotropic drugs; individuals who have allergies or who have some idiosyncratic response to any component of the product used in the research; patients who present parafunctional habits, eating disorders, gastric or emotional illness that is predisposed to dentin sensitivity; advanced medical or psychological illness; alcohol consumption or drug intoxication; hemorrhagic disease; systemic condition that is an etiological or predisposing factor for dentin sensitivity; diet with excessive exposure to acidic foods; individuals who underwent periodontal surgery or orthodontic treatment in the preceding 3 months; dental or periodontal pathologies, or defects that cause pain, such as caries, “brackets”, and extensive fillings; teeth that serve as "abutments" or support for fixed or removable dentures, or that have crowns; teeth with restorations that extend to the test area (cervical); teeth with irreversible pulp inflammation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: It is expected to find an improvement in dentin sensitivity, assessed by the VAS scale, the study's primary variable, in the 5% Sodium Fluoride group associated with Low Power Laser Therapy (F+LLLT) after 24 and 30 hours. 90 and 180 days.;Outcome found 1: Through the evaluation of the VAS pain scale, an improvement in dentin sensitivity was observed, it was observed that therapy (F) demonstrated the greatest reduction in hypersensitivity in 180 days, this being considered the therapy with the greatest effectiveness and effect lasting in the medium term. | — |
Secondary
| Measure | Time frame |
|---|---|
| It was not expected or evaluated. | — |
Countries
Brazil
Contacts
Universidade Estadual Paulista